Merck Says U.S. to Purchase 1.4 Million Doses of Covid Pill
Source: Merck & Co.
This article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
Merck & Co. said the U.S. committed to buy 1.4 million courses of its Covid-19 pill developed with Ridgeback Biotherapeutics LP for about $1 billion, bringing the country’s total to 3.1 million.